ReviewCurrent ophthalmology reports2021
The Future Is Now: Incorporating Telemedicine into Glaucoma Care.
Review in Current ophthalmology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Early Detection of Glaucoma and Diabetic Retinopathy in Low-Resource Settings: Barriers and Solutions.Journal of clinical medicine · 2026Review
- How patients deal with side-effects of topical intraocular pressure-lowering medication in glaucoma: a cross-sectional study from a tertiary ophthalmology clinic.International ophthalmology · 2025Article
- Current perspectives in tackling glaucoma blindness.Indian journal of ophthalmology · 2025Review
- Glaucoma Home Self-Testing Using VR Visual Fields and Rebound Tonometry Versus In-Clinic Perimetry and Goldmann Applanation Tonometry: A Pilot Study.Translational vision science & technology · 2024Article
- The impact of childhood glaucoma on psychosocial functioning and quality of life: a review of the literature.Eye (London, England) · 2023Review
- How glaucoma care changed for the better after the pandemic.Current opinion in ophthalmology · 2022Review
- Associations between Socioeconomic Factors and Visit Adherence among Patients with Glaucoma in the All of Us Research Program.Ophthalmology. GlaucomaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe field of teleglaucoma has expanded rapidly in recent years with several large-scale teleglaucoma screening programs in existence throughout the world. Additionally, teleglaucoma programs for use in disease management are under study. The limited access to care that resulted from the COVID-19 pandemic highlighted the need for expansion of such programs. This article reviews the literature on teleglaucoma for screening and management of glaucoma, discussing considerations for incorporating teleglaucoma into clinical practice. RECENT
findingsTeleglaucoma screening reduces the rate of false-positive referrals and can accurately screen at-risk populations with accuracy similar to in-person screening. The use of teleglaucoma for the management of glaucoma shows promise for low-risk patients with early disease. Furthermore, teleglaucoma is cost-effective and reduces travel burden for patients resulting in high patient satisfaction. SUMMARY: Teleglaucoma offers potential for improving access to glaucoma care, reducing the burden on patients and health care systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.